PureTech Health’s deupirfenidone (LYT-100) has received Orphan Drug Designation to treat idiopathic pulmonary fibrosis (IPF). The…
Continue ReadingTag: Pulmonary
Pulmonary Function Testing Market Size to Hit USD 5.66
Austin, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) — Pulmonary Function Testing Market Size & Growth Analysis:…
Continue Reading
Deep learning based CT images for lung function prediction in patients with chronic obstructive pulmonary disease | BMC Pulmonary Medicine
Study sample This study retrospectively selected individuals who underwent PFT and CT examinations at the Fourth…
Continue Reading
Editorial emphasizes the critical role of heart-lung interactions in pulmonary vascular disease
A new editorial published in Comprehensive Physiology underscores the critical importance of understanding heart-lung interactions in…
Continue Reading
Association of impaired pulmonary function and objectively measured physical activity in a population study
GOLD Report Global Initiative for Chronic Obstructive Lung Disease. (2023). The Global Asthma Report. Int. J.…
Continue Reading
Pulmonary function and motoric cognitive risk syndrome in older adults
Study design and participants The ELSA study is an ongoing, nationally representative, longitudinal study conducted among…
Continue Reading
Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD
Nerandomilast met its primary end point of absolute change from baseline in forced vital capacity (FVC)…
Continue Reading